1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. Belgium >
  6. UCB >
  7. M&A

UCB Mergers & Acquisitions

UCB M&A Summary

UCB has acquired 11 companies, including 3 in the last 5 years. It has also divested 7 assets.

UCB’s largest acquisition to date was in 2006, when it acquired Schwarz Pharma AG for $5.6B. It’s largest disclosed sale occurred in 2015, when it sold Kremers Urban Pharmaceuticals to Lannett Company for $1.2B. UCB has acquired in 5 different US states, and 3 countries. The Company’s most targeted sectors include life science (64%) and medical products (28%).

M&A Summary

  • M&A Total Activity18
    • M&A Buy Activity11
    • M&A Sell Activity7
  • Total Sectors Invested 3
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 8

UCB

UCB S.A.

Allee de la Recherche, 60,
Brussels, 1070
Belgium,
+32 2 559 99 99
www.ucb.com

All (18) Buy (11) Sell (7)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2024-03-04 IMIDomics · Life Science
San Rafael, California · www.imidomics.com.

IMIDomics is dedicated to the advancement of novel medicines for immune-mediated inflammatory diseases (IMIDs). IMIDomics was founded in 2015 and is based in San Rafael, California.

- Add-on Acquisition

UCB

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal